Cambridge Investment Research Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Buy |
|
|||||
|
2025
Q1 | $99K | Sell |
|
|||||
|
2024
Q4 | $110K | Buy |
|
|||||
|
2024
Q3 | $254K | Buy |
|
|||||
|
2024
Q2 | $345K | Sell |
|
|||||
|
2024
Q1 | $573K | Sell |
|
|||||
|
2023
Q4 | $807K | Buy |
|
|||||
|
2023
Q3 | $588K | Buy |
|
|||||
|
2023
Q2 | $601K | Buy |
|
|||||
|
2023
Q1 | $469K | Buy |
|
|||||
|
2022
Q4 | $568K | Sell |
|
|||||
|
2022
Q3 | $814K | Buy |
|
|||||
|
2022
Q2 | $773K | Buy |
|
|||||
|
2022
Q1 | $1.23M | Sell |
|
|||||
|
2021
Q4 | $1.75M | Sell |
|
|||||
|
2021
Q3 | $7.28M | Buy |
|
|||||
|
2021
Q2 | $5.39M | Buy |
|
|||||
|
2021
Q1 | $3.98M | Sell |
|
|||||
|
2020
Q4 | $7.11M | Buy |
|
|||||
|
2020
Q3 | $267K | Sell |
|
|||||
|
2020
Q2 | $432K | Buy |
|
|||||
|
2020
Q1 | $252K | Buy |
|
|||||
|
2019
Q4 | $228K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $200K | Sell |
|
|||||
|
2018
Q1 | $207K | Buy |
|